BioSpace News Archive

Advanced Instruments, a global provider of scientific and analytical instruments, announces the launch of Cell Metric® X, a high-contrast imager that offers automatic same-day identification of clonally derived cells.

AltruBio Inc. (“AltruBio” or “the Company”) today announced that David T. Rubin, M.D., Professor of Medicine at the University of Chicago and AltruBio Scientific Advisory Board member, will share a poster presentation on first-generation immune checkpoint enhancer (ICE), ALTB-168 (neihulizumab), at the Crohn’s & Colitis Congress 2023, to be held in Denver, Colorado on January 19-21, 2023.

Known Medicine, a rising biotechnology company, has been awarded the prestigious “Best Use of Artificial Intelligence in BioTech 2022” by BioTech Breakthrough Awards.

Lipidomics, a platform developed by Creative Proteomics, is dedicated to providing cutting-edge mass spectrometry (MS)-based lipidomic research services for biomedical institutions as well as biotechnological and pharmaceutical companies

ResoluteAI, the research platform for science, launched today a Clinical Trials Analytics package that connects clinical trial data with research publications and other datasets.

Metabolomics, a division of Creative Proteomics, is dedicated to providing cutting-edge LC-MS-based metabolomics services for biomedical research institutions as well as biotechnological and pharmaceutical companies.

Pulmobiotics SL and the Centre for Genomic Regulation (CRG) today announced the publication of preclinical results demonstrating that treatment using Pulmobiotics’ engineered live biotherapeutic significantly reduced antibiotic-resistant Pseudomonas aeruginosa infections in the lungs of mice, thereby improving survival rates, and dissolved biofilms formed on endotracheal tubes of patients with ventilator-associated pneumonia (VAP).

Intera Oncology® Inc., the manufacturer of the only FDA-approved implantable pump used for hepatic artery infusion (HAI) therapy, will showcase its Intera 3000 HAI Pump at the 2023 ASCO Gastrointestinal Cancer Symposium, taking place at the Moscone West in San Francisco, Calif. from January 19 to 20, 2023.

Avectas, a cell engineering technology leader, announces the launch of the Solupore platform at the Advanced Therapies Week, Miami Beach Convention Centre, January 17th - 20th, 2023, Booth # 331

Over the past few years, there has been an influx of cluster of innovative cancer therapies for the patients but the heightened excitement that immunotherapy market has brought for wide variety of tumor types is approaching one-size-fits-all approach.